Durham Drug Developer Viamet Pharmaceuticals Files For $75 Million IPO

Published: Jul 08, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Durham drug developer Viamet Pharmaceuticals filed initial paperwork for a public offering.

According to the initial filing with the Securities and Exchange Commission, Viamet proposes to raise a maximum of $75 million, though that figure is estimated only to determine a registration fee and will likely change by time Viamet completes the initial public offering.

Help employers find you! Check out all the jobs and post your resume.

Back to news